Optimind Pharma Corp. (CSE:OMND)
0.0050
0.00 (0.00%)
At close: Sep 11, 2025
Optimind Pharma Revenue
Optimind Pharma had revenue of 16.55K CAD in the quarter ending August 31, 2026, a decrease of -38.83%. This brings the company's total for the last twelve months to 91.63K, down -26.11% year-over-year. In the fiscal year ending February 28, 2026, Optimind Pharma had annual revenue of 121.29K with 2.47% growth. That makes Optimind Pharma the 46,434th largest company in the world by revenue and 1,072nd in Canada.
Revenue (ttm)
91.63K
Revenue Growth
-26.11%
P/S Ratio
5.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
515.74K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2026 | 121.29K | 2.93K | 2.47% |
| Feb 28, 2025 | 118.37K | -4.59K | -3.73% |
| Feb 29, 2024 | 122.96K | -47.15K | -27.72% |
| Feb 28, 2023 | 170.11K | 70.42K | 70.64% |
| Feb 28, 2022 | 99.69K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vibe Growth | 26.34M |
| Aequus Pharmaceuticals | 918.47K |
| Ovation Science | 57.34K |
| Genix Pharmaceuticals | 68.00 |
| Captor Capital | -5.05M |